With this contract dossier whose conditions are established in this specification, it is intended to cover the needs in Osakidetza for the use of the medicines included in the dossier for the therapeutic indications approved by the competent health authority and which are summarized in the report's memory.
Centralized contracting of the supply of the Ondansetron (DOE) non-buco-dispensed compressed drug, for all Osakidetza service organizations and privately owned and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in Article 30 of Law 8/1997, of June 26, on the Health Organization of Euskadi, which sign a relationship agreement with Osakidetza / Basque Health Service.
Lot one - Ondansetron (DOE) non-orodispensable tablet.
Amount of active substance: 4 mg and 8 mg.
Pharmaceutical form: non-orodispensable tablet
Packaging conditions: preferred unit dose
Maximum price: 0.11 euros / non-orodispensable tablet of 4 mg / 0.15 euros / non-orodispensable tablet of 8 mg (taxes not included)
Number of units planned: 25,000 non-orodispensable 4 mg tablet
(first year of contract) 35 000 non-orodispensable 8 mg tablet
Maximum estimated budget: EUR 8,000.00
(first year of contract)
Active substance: LAMIVUDINA (DOE)
Amount of active substance: 150 mg and 300 mg
Pharmaceutical Form: tablet
Packaging conditions: unit dose preferably
Maximum price: 0.20 euros / 150 mg tablet
(Taxes not included) 0.40 euros / 300 mg tablet
N
140,000 tablets of 300mg
Maximum estimated budget: 59,200.00 euros
(First year of contract)
Active substance: PHENYLBUTIRATE (DOE)
Amount of active substance: 500 mg
Pharmaceutical Form: tablet
Packaging conditions: unit dose preferably
Maximum price: 612.49 euros / pack of 250 tablets
(Taxes not included)
N
(First year of contract)
Maximum estimated budget: 55,124.10 euros
Centralized contracting of the supply of the ONDANSETRON (DOE) orodispensable compressed medicine, for all Osakidetza service organizations and privately owned and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in Article 30 of Law 8/1997, of June 26, on the Health Organization of Euskadi, which signs a relationship agreement with Osakidetza / Basque Health Service.
Lot one - ONDANSETRON (DOE) orodispensable tablet.
Amount of active substance: 4 mg and 8 mg.
Pharmaceutical form: orodispensable tablet
Packaging conditions: unit dose preferably
Maximum price: 0.11 euros / 4 mg orodispensable tablet // 0.15 euros / orodispensable tablet
(Taxes not included)
Number of units planned: 25,000 non-orodispensable 4 mg tablet
(first year of contract) 35,000 non-orodispensable 8 mg tablet
Maximum estimated budget: 8,000.00 euros
(first year of contract)
Centralized contracting of the supply of the ONDANSETRON (DOE) blister, for all Osakidetza service organizations and privately owned and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of the Law 8/1997, of June 26, on the Health Organization of Euskadi, which signs a linkage agreement with Osakidetza / Basque Health Service.
Lot one - ONDANSETRON (DOE) blister.
Amount of active substance: 4 mg and 8 mg.
Pharmaceutical form: blister
Packaging conditions: unit dose
Maximum price: 0.13 euros / 4 mg vial // 0.18 euros / 8 mg vial (Taxes not included)
(Taxes not included)
Number of units planned: 150,000 4 mg ampoules
(first year of contract) 60,000 8 mg ampoules
Maximum estimated budget: 30,300.00 euros
(first year of contract)
Centralized contracting of the supply of the GRANISETRON (DOE) medicine, for all Osakidetza service organizations and private and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of the Law 8/1997, of June 26, of the Health Organization of Euskadi, that sign an agreement with Osakidetza / Basque Health Service.
Lot one - GRANISETRON (DOE) compressed.
Amount of active substance: 1 mg.
Pharmaceutical form: tablet
Packaging conditions: unit dose preferably
Maximum price: 1.35 euros / 1 mg tablet (Taxes not included)
(Taxes not included)
Number of units planned: 1,500 tablets of 1 mg
(first year of contract)
Maximum estimated budget: 2,025.00 euros
(first year of contract)
Centralized contracting of the supply of the GRANISETRON (DOE) medicine, for all Osakidetza service organizations and private and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of the Law 8/1997, of June 26, of the Health Organization of Euskadi, that sign an agreement with Osakidetza / Basque Health Service.
Lot one - GRANISETRON (DOE) blister.
Amount of active substance: 1 mg.
Pharmaceutical form: blister
Packaging conditions: unit dose
Maximum price: 0.46 euros / 1 ml ampoule
(Taxes not included)
Number of units planned: 8,000 1 ml ampoules
(first year of contract)
Maximum estimated budget: 3,680.00 euros
(first year of contract)
Active substance: PARACETAMOL (DOE)
Amount of active substance: 1 g
Pharmaceutical Form: bag
Packaging conditions: unit dose
Maximum price: 0.44 euros / bag
(Taxes not included)
N
(First year of contract)
Maximum estimated budget: 154,000.00 euros
(First year of contract)
Active substance: PARACETAMOL (DOE)
Amount of active substance: 1 g
Pharmaceutical Form: vial / glass jar
Packaging conditions: unit dose
Maximum price: 0.42 euros / vial / glass jar
(Taxes not included)
N
(First year of contract)
Maximum estimated budget: 2,100.00 euros
(First year of contract)
Active substance: PARACETAMOL (DOE)
Amount of active substance: 1 g
Pharmaceutical Form: plastic vial / vial
Packaging conditions: unit dose
Maximum price: 0.44 euros / vial / plastic bottle
(Taxes not included)
N
(First year of contract)
Maximum estimated budget: 286,000.00 euros
(First year of contract)
Active substance: LAMIVUDINA (DOE)
Amount of active substance: 100 mg
Pharmaceutical Form: tablet
Packaging conditions: unit dose preferably
Maximum price: 0.28 euros / 100 mg tablet
(Taxes not included)
N
(First year of contract)
Maximum estimated budget: 28,000.00 euros
(First year of contract)